| protein
| carnitine palmitoyltransferase I, CPT1 ( |
|
calcineurin ( |
|
harakiri, HRK ( |
|
p28 Bap31 ( |
|
BNIP1 variants ( |
|
BCL2-associated transcription factor 1, BCLAF1 ( |
|
paxillin, PXN ( |
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like, BNIP3L ( |
|
RAS ( |
|
Presenilin 1, PS1 ( |
|
BCL2/adenovirus E1B 19kDa interacting protein 3, BNIP3 ( |
|
modulator of apoptosis 1, MOAP1 ( |
|
PP1alpha and Bad ( |
|
poly (ADP-ribose) polymerase, PARP ( |
|
cis-trans peptidyl prolyl isomerase, Pin1 ( |
|
integral membrane protein 2B, ITM2B ( |
|
FK506 binding protein 8, 38kDa, FKBP38 ( |
|
binding and inactivating APAF1 |
|
BAX ( |
|
RAF1, TP53BP2 |
|
BCL2/adenovirus E1B 19kD interacting protein like 2, BNIPL-2 ( |
|
orphan nuclear receptor Nur77 ( |
|
BCL2-associated agonist of cell death, BAD ( |
|
NALP1, reducing caspase-1 activation and interleukin-1beta, IL-1beta ( |
|
interaction between HNRNPL and CA repeats of BCL2 mRNA participates in destabilizing BCL2 mRNA |
|
SOD1, through its N-terminal portion between the BH4 and the loop domain |
|
beclin 1, autophagy related, BECN1 ( |
|
BCL2 anti-apoptotic and autophagy inhibitory protein, is a substrate for parkin (PARK2) |
|
BCL2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in C6 glioma cells ( |
|
|
|
LGALS7 is a new mitochondrial BCL2 interacting partner |
|
a dynamic interaction exists between AMBRA1 and BC-2 at the mitochondria that could regulate both BECLIN 1-dependent autophagy and apoptosis) |
|
during early apoptosis, SATB1 was a key regulator of BCL2 expression |
|
BRCA1, which plays an essential role in homologous recombination (HR), is a target for BCL2 in the repression of HR |
|
ATG12 directly regulates the apoptotic pathway by binding and inactivating prosurvival BCL2 family members, including BCL2 and MCL1 |
|
role of NFE2L2 in control of BCL2 expression and apoptotic cell death with implications in antioxidant protection, survival of cancer cells, and drug resistance |
|
FKBP8 is a regulator of the prosurvival protein BCL2 |
|
induces autophagy by disrupting the association between BCL2 and BECN1 |
|
RRM2 regulates BCL2 protein stability, with RRM2 suppression leading to increased BCL2 degradation, and critical link between RRM2 and BCL2 in apoptosis signaling |
|
interaction between BCL2 and BL2L1 with a stress chaperone, mortalin (HSPA9) |
|
regulates apoptosis through unique interactions with multiple regulators including BCL2 |
|
BCL2 directly binds to the phagophore-associated protein GABARAP |
|
BCL2 proteins suppressed mitophagy through inhibition of PARK2 translocation to depolarized mitochondria |
|
ZFP36L1 interacting with and mediating degradation of BCL2 mRNA as an important target through which ZFP36L1 mediates its pro-apoptotic effects in malignant B-cells |
|
correlation of GPR65 with BCL2 suggesting a novel cytoprotective mechanism that enables chronic lymphocytic leukemia (CLL) cell adaptation to acidic extracellular conditions |
|
EXOC4 is involved in the regulation of both BCL2 and MCL1 at the mRNA level |
|
EXOC3 regulated BCL2 at the mRNA level and the binding affinity of F-box and WD repeat domain containing 7 and MCL1, thereby controlling MCL1 at the protein level |
|
DACH1 expression regulates the pancreatic cancer cell apoptosis through interacting with BCL2 signaling axis, whereas it controls cell migration and invasion via epithelial-mesenchymal transition (EMT) process |
|
ANKRD1 can protect against H/R induced cardiomyocyte apoptosis, possibly through increasing anti-apoptosis BCL2 gene expression |
|
BCL2 proteins directly promote SUFU turnover, inhibit SUFU-GLI interaction, and induce the expression of the GLI target genes BCL2, MCL1 and BCL2L1 |
|
XIAP serves as an E3 ligase for BCL2 and SEPTIN4 is essential for this process |
|
physical interaction of BCL2 with SAV1 was correlated with proteasomal degradation of SAV1 and STK3 proteins |
|
BCL2 acted as the target of METTL3, thereby regulating the proliferation and apoptosis of breast cancer |
